SIS-401-PACA

N/A

Report date: 2023/10/23 15:34:22
NME

Base Information

Drug NameSIS-401-PACA
Drug Alias NameSIS-401-PACA
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionRNA interference
TargetsUpdating
Therapy Area/IndicationsSolid tumoursPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSiSaf Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSiSaf Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A